TrialClinical drug investigation2019

Cost-Effectiveness Analysis of Erenumab Versus OnabotulinumtoxinA for Patients with Chronic Migraine Attacks in Greece.

Theodoros V Giannouchos et al.PubMed ↗Publisher ↗

No numbers read from the abstract.